Form 8-K - Current report:
SEC Accession No. 0001213900-24-014713
Filing Date
2024-02-16
Accepted
2024-02-16 08:00:11
Documents
16
Period of Report
2024-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193963-8k_incannex.htm   iXBRL 8-K 30104
2 PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED FEBRUARY 16, 2024 ea193963ex99-1_incannex.htm EX-99.1 17093
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3710
  Complete submission text file 0001213900-24-014713.txt   232370

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ixhl-20240216.xsd EX-101.SCH 3024
5 XBRL LABEL FILE ixhl-20240216_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ixhl-20240216_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT ea193963-8k_incannex_htm.xml XML 3719
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 24645830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)